http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002022746-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d3c3aaa4a1d4429fef8dd7a48d3096e |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2000-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d242712a9cc997a7465c883b8d23820f |
| publicationDate | 2002-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2002022746-A |
| titleOfInvention | Early diagnosis of cancer |
| abstract | (57) [Summary] [PROBLEMS] To provide a novel tumor marker, 1) brain tumor, 2) cholangiocarcinoma, 3) gallbladder cancer, 4) ovarian cancer, 5) renal cancer, 6) pancreatic cancer, 7) lung adenocarcinoma, 8) large cell lung cancer, 9) To provide an appropriate diagnostic marker for lung squamous cell carcinoma, 10) Lung small cell carcinoma. A known type I collagen C-terminal non-triple chain telopeptide (1CTP) is used for 1) brain tumor, 2) cholangiocarcinoma, 3) gallbladder cancer, 4) ovarian cancer, 5) kidney cancer, 6) pancreatic cancer, 7) Used as an appropriate diagnostic marker for lung adenocarcinoma, 8) large cell lung cancer, 9) squamous cell lung cancer, 10) small cell lung cancer. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004011945-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003240774-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004011945-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010031822-A1 |
| priorityDate | 2000-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 52.